HomeCompareZBH vs MA

ZBH vs MA: Dividend Comparison 2026

ZBH yields 1.08% · MA yields 0.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MA wins by $476.0K in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
MA
MA
● Live price
0.64%
Share price
$494.00
Annual div
$3.15
5Y div CAGR
91.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$497.2K
Annual income
$341,049.48
Full MA calculator →

Portfolio growth — ZBH vs MA

📍 MA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHMA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + MA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
MA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
MA
Annual income on $10K today (after 15% tax)
$54.20/yr
After 10yr DRIP, annual income (after tax)
$289,892.06/yr
At 15% tax rate, MA beats the other by $289,791.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + MA for your $10,000?

ZBH: 50%MA: 50%
100% MA50/50100% ZBH
Portfolio after 10yr
$259.2K
Annual income
$170,584.06/yr
Blended yield
65.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MA right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
MA
Analyst Ratings
1
Strong
51
Buy
12
Hold
Consensus: Buy
Price Target
$667.33
+35.1% upside vs current
Range: $610.00 — $739.00
Altman Z
9.7
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
0
MA buys
8
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$MA▼ Sell$1,001 - $15,0002026-02-23
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Michael McCaul🏢 House$MA▼ Sell$1,001 - $15,0002025-10-27
Gilbert Cisneros🏢 House$MA▲ Buy$1,001 - $15,0002025-10-17
Val Hoyle🏢 House$MA▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$MA▲ Buy$1,000 - $15,0002025-08-04
Lisa McClain🏢 House$MA▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$MA▲ Buy$1,001 - $15,0002025-06-17
Michael McCaul🏢 House$MA▼ Sell$15,001 - $50,0002025-06-16
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHMA
Forward yield1.08%0.64%
Annual dividend / share$0.96$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%91.8%
Portfolio after 10y$21.2K$497.2K
Annual income after 10y$118.64$341,049.48
Total dividends collected$1.1K$463.2K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldBuy
Analyst price target$105.60$667.33

Year-by-year: ZBH vs MA ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrMA PortfolioMA Income/yrGap
1← crossover$10,809$108.54$10,822$122.30$13.00MA
2$11,675$109.86$11,817$237.26$142.00MA
3$12,603$111.13$13,109$464.38$506.00MA
4$13,598$112.34$14,950$923.39$1.4KMA
5$14,663$113.51$17,884$1,887.66$3.2KMA
6$15,804$114.62$23,183$4,047.78$7.4KMA
7$17,026$115.69$34,212$9,405.89$17.2KMA
8$18,335$116.71$61,488$24,880.97$43.2KMA
9$19,736$117.70$145,949$80,157.01$126.2KMA
10$21,236$118.64$497,215$341,049.48$476.0KMA

ZBH vs MA: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

MAFinancials

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; prepaid programs and management services; commercial credit and debit payment products and solutions; and payment products and solutions that allow its customers to access funds in deposit and other accounts. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Full MA Calculator →
📬

Get this ZBH vs MA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.